Lake Street initiated coverage of OrthoPediatrics (KIDS) with a Buy rating and $37 price target OrthoPediatrics has proven out its founding thesis that a focused pediatric orthopedics firm is needed and can generate strong economic returns, says the analyst, who argues that the company “occupies a Goldilocks position in an overlooked market.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KIDS:
- OrthoPediatrics: Strong Market Position and Growth Potential Justify Buy Rating with $50 Price Target
- Orthopediatrics Corp Faces Financial Uncertainty Amidst Trade and Regulatory Challenges
- OrthoPediatrics Corp’s Earnings Call Highlights Growth and Record Impact
- OrthoPediatrics price target lowered to $32 from $40 at Stifel
- OrthoPediatrics’ Promising Growth Prospects Reinforce Buy Rating
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue